NCT06496074

Brief Summary

Head-up tilt test (HUTT) is widely used to evaluate patients with unexplained syncope, but data on clinical predictors of HUTT results are limited. The investigators aim to evaluate heart rate (HR) variations and blood pressure (BP) changes associated with the HUTT results and the difference according to the gender. For this, a cross-sectional study will be performed with patients attended with unexplained syncope submitted to HUTT (70-degree angle), from January/2011 to April/2015. The investigators will analyze BP changes and Receiver-Operating Characteristics (ROC) curves for the maximum interval in HR variation from the first minute to tenth minute (delta-HR 10) after tilting. The significance level will be considered at 5%.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
149

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 2, 2024

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

July 3, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 11, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 2, 2024

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 2, 2025

Completed
Last Updated

September 26, 2024

Status Verified

September 1, 2024

Enrollment Period

2 months

First QC Date

July 3, 2024

Last Update Submit

September 24, 2024

Conditions

Keywords

Vasovagal syncopeTilt-table testHeart rate variationBlood pressureHemodynamics

Outcome Measures

Primary Outcomes (1)

  • Positive diagnostic correlation

    Positive diagnostic correlation of the data obtained in group 1 (positive head-up tilt test) in relation to group 2 (negative head-up tilt test).

    30 days

Secondary Outcomes (2)

  • Blood pressure variation in the head-up tilt test

    30 days

  • Heart rate variation in the head-up tilt test

    30 days

Study Arms (2)

Positive head-up tilt test

Patients who underwent to head-up tilt test (HUTT) and met criteria for positive exam according to the defined in guidelines.

Diagnostic Test: Head-up Tilt Test

Negative head-up tilt test

Patients who underwent to head-up tilt test (HUTT) and did not met criteria for positive exam according to the defined in guidelines.

Diagnostic Test: Head-up Tilt Test

Interventions

Head-up Tilt TestDIAGNOSTIC_TEST

Two protocols for the head-up tilt test (HUTT) are used in our center and in the collaborating centers: (1) passive or prolonged inclination protocol \[40 minutes\], (2) mixed protocol: passive phase \[first 20 minutes\] plus nitrate-provoked phase \[last 20 minutes\], with the use of 1.25 mg sublingual isosorbide dinitrate. All patients are submitted to 10 minutes of rest in the supine position at zero degree before the tilt phase of the HUTT. During this period, HR and systolic (SBP) and diastolic (DBP) measurements are obtained every 2 minutes. After this phase, the table is tilted at an angle of 70° with measurement of SBP / DBP and HR every minute. Patients older than 60 years are routinely investigated for carotid sinus hypersensitivity by carotid sinus massage during the passive phase of the HUTT. The exam is considered positive according to the criteria defined in guidelines.

Negative head-up tilt testPositive head-up tilt test

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients ≥ 18 years old, male or female, with the presence of the inclusion criteria and without exclusion criteria, attended with a history of syncope submitted to head-up tilt test, between January 2011 and April 2015, by the Federal University of Piaui, Brazil in co-participation with the private sector including the Clinicardio and the ITACOR Hospital, specialized centers for diagnosis and treatment of the heart disease.

You may qualify if:

  • Patients ≥ 18 years old
  • Patients attended with a history of syncope submitted to head-up tilt test

You may not qualify if:

  • Patients \< 18 years old
  • Patients without a history of true syncope
  • Patients who did not submit to head-up tilt test
  • Withdrawal of the consent form at the request of the patient or guardian

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Carlos Eduardo Batista de Lima

Teresina, Piauí, 64048-350, Brazil

Location

Related Publications (1)

  • de Lima CEB, da Silva PAD, de Sa Nascimento SRA, de Freitas MVA, de Area Leao Moreira FG, Silvino VO, Ramos RM, Pereira Dos Santos MA. Sex-Specific heart rate acceleration as predictors of positive head-up tilt test outcomes in syncope patients. BMC Cardiovasc Disord. 2025 Nov 11;25(1):800. doi: 10.1186/s12872-025-05290-7.

MeSH Terms

Conditions

Syncope, Vasovagal

Condition Hierarchy (Ancestors)

Orthostatic IntolerancePrimary DysautonomiasAutonomic Nervous System DiseasesNervous System DiseasesSyncopeUnconsciousnessConsciousness DisordersNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Carlos Eduardo Batista Lima, MD, PhD

    Federal University of Piaui

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Medicine (Cardiology)

Study Record Dates

First Submitted

July 3, 2024

First Posted

July 11, 2024

Study Start

July 2, 2024

Primary Completion

September 2, 2024

Study Completion

July 2, 2025

Last Updated

September 26, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

I have no plan to share individual patient data with other researchers.

Locations